VU0364289
VU0364289 is a highly selective mGlu5 positive allosteric modulator (PAM) (binds to the MPEP site), with an EC50 of 1.6 μM. VU0364289 can reverse amphetamine-induced hyperlocomotion in a dose-dependent manner, which can be used for schizophrenia and other psychiatric research[1][2][3].
Product Specifications
CAS Number
1242443-29-3
UNSPSC
12352005
Hazard Statement
H315, H319
Target
MGluR
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/vu0364289.html
Purity
99.52
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N#CC1=CC=CC=C1N2CCN(CC2)C(COCC3=CC=CC=C3)=O
Molecular Formula
C20H21N3O2
Molecular Weight
335.40
Precautions
H315, H319
References & Citations
[1]Gregory KJ, et al. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement. J Pharmacol Exp Ther. 2013 Nov;347 (2) :438-57. |[2]Ya Zhou, et al. Discovery of N-Aryl Piperazines as Selective mGluR5Potentiators with Improved In Vivo Utility. ACS medicinal chemistry letters, 2010, 1 (8) : 433-438.|[3]Psychosis Models[M]//Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer, New Delhi, 2016: 731-750.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
MGluR5
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041537-500 1x 500 µL
Beta-2 Microglobulin (Renal Failure &Tumor Marker) (rB2M/961), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNCB1335-500 1x 500 µL
Helicobacter pylori (HP/1335), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681783-500 1x 500 µL
CD45RB (B-Cell Marker) (PTPRC/1783R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
